You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 60 No. 8, August 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (83)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Multiple Sclerosis/ Demyelinating Disease
 •Radiologic Imaging
 •Magnetic Resonance Imaging
 •Immunologic Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Remyelinated Lesions in Multiple Sclerosis

Magnetic Resonance Image Appearance

Frederik Barkhof, MD, PhD; Wolfgang Brück, MD, PhD; Corline J. A. De Groot, PhD; Elisabeth Bergers, MD, PhD; Sandra Hulshof, MD; Jeroen Geurts, MD; Chris H. Polman, MD, PhD; Paul van der Valk, MD, PhD

Arch Neurol. 2003;60:1073-1081.

Background  Various types of pathologic mechanisms in multiple sclerosis (MS) can alter magnetic resonance imaging (MRI) signals, and the appearance of remyelinated lesions on MRI is largely unknown.

Objective  To describe the MRI appearance of remyelinated lesions in MS.

Design  Comparison of postmortem MRI findings with histopathologic findings.

Setting  Brain donations from a general community.

Patients  Magnetic resonance images from 36 rapid autopsies yielded 161 areas that could be matched with histologic characteristics, including 149 focal T2-weighted abnormalities, with a range of signal intensities on T1-weighted images. In a subset of 49 lesions, magnetization transfer ratio could be determined.

Main Outcome Measures  An observer blinded to the MRI findings assessed the presence of remyelination using light microscopic criteria; in 25 areas, in situ hybridization was used to assess the presence of oligodendrocytes expressing proteolipid protein messenger RNA.

Results  Remyelinated areas were found in 67 lesions (42%): partial remyelination was present in 30 lesions (19%), whereas 37 lesions (23%) were fully remyelinated. Remyelinated lesions contained enhanced numbers of oligodendrocytes containing proteolipid protein messenger RNA. All areas with remyelination shown histopathologically were hyperintense on T2-weighted images. Strong hypointensity on T1-weighted images was significantly associated ({chi}2 = 29.8, P<.001) with demyelinated and partially remyelinated lesions compared with fully remyelinated lesions. The magnetization transfer ratio of remyelinated lesions (mean [SD], 27.6% [41%]) differed (F = 46.3, P<.001) from both normal-appearing white matter (35.2% [32%]) and demyelinated lesions (22.3% [48%]).

Conclusions  Remyelinated lesions return an abnormal signal on T2-weighted images. Both T1-weighted images and magnetization transfer ratio may have (limited) additional value in separating lesions with and without remyelination.


From the Dutch MR-MS Center, and the Departments of Radiology (Drs Barkhof, Bergers, Geurts, and van der Valk), Pathology (Drs De Groot and Hulshof), and Neurology (Dr Polman), Vrije Universiteit Medical Center, Amsterdam, the Netherlands; and the Department of Neuropathology, Charité Hospital, Berlin, Germany (Dr Brück).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Remyelination capacity of the MS brain decreases with disease chronicity
Goldschmidt et al.
Neurology 2009;72:1914-1921.
ABSTRACT | FULL TEXT  

Measuring Demyelination and Remyelination in Acute Multiple Sclerosis Lesion Voxels
Giacomini et al.
Arch Neurol 2009;66:375-381.
ABSTRACT | FULL TEXT  

Outcome measures for trials of remyelinating agents in multiple sclerosis: retrospective longitudinal analysis of visual evoked potential latency
Niklas et al.
Mult Scler 2009;15:68-74.
ABSTRACT  

Negative Impact of Statins on Oligodendrocytes and Myelin Formation In Vitro and In Vivo
Klopfleisch et al.
J. Neurosci. 2008;28:13609-13614.
ABSTRACT | FULL TEXT  

From fish to man: understanding endogenous remyelination in central nervous system demyelinating diseases
Dubois-Dalcq et al.
Brain 2008;131:1686-1700.
ABSTRACT | FULL TEXT  

Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis
Kuhlmann et al.
Brain 2008;131:1749-1758.
ABSTRACT | FULL TEXT  

Cognitive impairment in relapsing--remitting multiple sclerosis can be predicted by imaging performed several years earlier
Summers et al.
Mult Scler 2008;14:197-204.
ABSTRACT  

Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement
Vellinga et al.
Brain 2008;131:800-807.
ABSTRACT | FULL TEXT  

MR Imaging Intensity Modeling of Damage and Repair In Multiple Sclerosis: Relationship of Short-Term Lesion Recovery to Progression and Disability
Meier et al.
Am. J. Neuroradiol. 2007;28:1956-1963.
ABSTRACT | FULL TEXT  

Optic nerve magnetization transfer imaging and measures of axonal loss and demyelination in optic neuritis
Trip et al.
Mult Scler 2007;13:875-879.
ABSTRACT  

Early MRI changes in a mouse model of multiple sclerosis are predictive of severe inflammatory tissue damage
Nessler et al.
Brain 2007;130:2186-2198.
ABSTRACT | FULL TEXT  

Can clinical outcomes be used to detect neuroprotection in multiple sclerosis?
Khan
Neurology 2007;68:S64-S71.
ABSTRACT | FULL TEXT  

Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis?
Zivadinov
Neurology 2007;68:S72-S82.
ABSTRACT | FULL TEXT  

Voxel-based analysis of grey matter magnetization transfer ratio maps in early relapsing remitting multiple sclerosis
Audoin et al.
Mult Scler 2007;13:483-489.
ABSTRACT  

MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS
Miller et al.
Neurology 2007;68:1390-1401.
ABSTRACT | FULL TEXT  

Remyelination is extensive in a subset of multiple sclerosis patients
Patrikios et al.
Brain 2006;129:3165-3172.
ABSTRACT | FULL TEXT  

Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis
De Stefano et al.
Brain 2006;129:2008-2016.
ABSTRACT | FULL TEXT  

Imaging of CNS myelin by positron-emission tomography
Stankoff et al.
Proc. Natl. Acad. Sci. USA 2006;103:9304-9309.
ABSTRACT | FULL TEXT  

Multiple Sclerosis: The Role of MR Imaging
Ge
Am. J. Neuroradiol. 2006;27:1165-1176.
ABSTRACT | FULL TEXT  

Selective magnetization transfer ratio decrease in the visual cortex following optic neuritis
Audoin et al.
Brain 2006;129:1031-1039.
ABSTRACT | FULL TEXT  

MTI of white matter hyperintensities
Fazekas et al.
Brain 2005;128:2926-2932.
ABSTRACT | FULL TEXT  

Magnetization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosis
Fernando et al.
Brain 2005;128:2911-2925.
ABSTRACT | FULL TEXT  

Multiple Sclerosis and Black Holes: Connecting the Pixels
Naismith and Cross
Arch Neurol 2005;62:1666-1668.
FULL TEXT  

Patterns of enhancing lesion evolution in multiple sclerosis are uniform within patients
Minneboo et al.
Neurology 2005;65:56-61.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.